Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation

被引:0
作者
You-Jung Choi
Bongseong Kim
Tae-Min Rhee
Hyun-Jung Lee
Heesun Lee
Jun-Bean Park
Seung-Pyo Lee
Kyung-Do Han
Yong-Jin Kim
Hyung-Kwan Kim
机构
[1] Korea University Guro Hospital & Korea University College of Medicine,Division of Cardiology, Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] The Catholic University of Korea,Department of Biostatistics
[4] Seoul National University Hospital,Division of Cardiology, Department of Internal Medicine
[5] Seoul National University Hospital,Healthcare System Gangnam Center
[6] Soongsil University,Department of Statistics and Actuarial Science
[7] Seoul National University Hospital & Seoul National University College of Medicine,Section of Cardiovascular Imaging, Division of Cardiology, Department of Internal Medicine, Cardiovascular Center
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although atrial fibrillation (AF) is a well-established risk factor for ischemic stroke (IS) in hypertrophic cardiomyopathy (HCM), the risk of IS in HCM patients without documented AF is less recognized. This nationwide population-based cohort study using Korean National Health Insurance database included 8,328 HCM patients without documented AF and 1:2 propensity score-matched 16,656 non-HCM controls between 2010 and 2016. The primary outcome was an incident IS. During a mean follow-up of 6.1 years, IS occurred in 328/8,328 (3.9%) patients with HCM and 443/16,656 (2.7%) controls. The overall incidence of IS was 0.72/100 person-years in the HCM group, which was significantly higher than that in the control group (0.44/100 person-years) (HR 1.64; 95% CI 1.424–1.895; P < 0.001). The overall incidence of IS was 1.36/100 person-years in HCM patients aged ≥ 65 and 2.32/100 person-years years in those with heart failure, respectively. In the HCM group, age ≥ 65 years (adjusted HR 2.74; 95% CI 2.156–3.486; P < 0.001) and chronic heart failure (adjusted HR 1.75; 95% CI 1.101–2.745; P = 0.018) were independent risk factors for IS. HCM patients without documented AF are at a greater risk of IS, especially in those 65 years of age or older or those with chronic heart failure.
引用
收藏
相关论文
共 51 条
  • [1] Watkins H(2011)Inherited cardiomyopathies N. Engl. J. Med. 364 1643-1656
  • [2] Ashrafian H(2017)Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy Circ. Res. 121 749-770
  • [3] Redwood C(2017)Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy Circulation 136 2420-2436
  • [4] Marian AJ(2018)Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study Int. J. Cardiol. 273 130-135
  • [5] Braunwald E(2019)Novel oral anticoagulants for primary stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation Stroke 50 2582-2586
  • [6] Rowin EJ(2020)2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 142 e533-e557
  • [7] Choi YJ(2016)Stroke and embolic events in hypertrophic cardiomyopathy: Risk stratification in patients without atrial fibrillation Stroke 47 936-942
  • [8] Lee HJ(2019)Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation: A nationwide cohort study Aging 11 11347-11357
  • [9] Ommen SR(2022)Ischemic stroke in patients with hypertrophic cardiomyopathy according to presence or absence of atrial fibrillation Stroke 53 497-504
  • [10] Haruki S(2014)Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: Systematic review Heart 100 465-472